Article

A broken trust: lessons from the vaccine--autism wars.

PLoS Biology, Public Library of Science, San Francisco, California, United States of America.
PLoS Biology (Impact Factor: 11.77). 06/2009; 7(5):e1000114. DOI: 10.1371/journal.pbio.1000114
Source: PubMed

ABSTRACT Researchers long ago rejected the theory that vaccines cause autism, yet many parents don't believe them. Can scientists bridge the gap between evidence and doubt?

0 Bookmarks
 · 
127 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Aim: The aim of this study was to describe how nurses in child health centres deal with parents who are hesitant to child vaccinations. Method: A study with a qualitative approach that was based on 12 semi-structured interviews. The informants were nurses working in child health centres in the Västra Götaland region. The interviews were analysed using qualitative content analysis. Results: The results identified six strategies for dealing with vaccine-hesitant parents: 1) using the family’s resources and knowledge to create a trusting relationship; 2) meetings with the same nurse; 3) open dialogue and active listening; 4) regular meetings between nurse and paediatrician; 5) nurse training on new vaccines and vaccination programme; and 6) nurse training on parents’ use of publicly available information. Conclusion: Nurses should get to know the vaccine-hesitant parents, by listening to them and understanding their point of view. Thereby, nurses establish a good relationship, inspire trust and actively involve the parents in the decision-making concerning the vaccination of their child. Nurses should not make vaccine-hesitant parents feel guilty about not wanting to vaccinate their child.
    08/2014; 2(4):47-59. DOI:10.5430/cns.v2n4p47
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There has been a substantial increase in research activity on autism during the past decade. Research into effective ways of responding to the immediate needs of autistic people is, however, less advanced, as are efforts at translating basic science research into service provision. Involving community members in research is one potential way of reducing this gap. This study therefore investigated the views of community involvement in autism research both from the perspectives of autism researchers and of community members, including autistic adults, family members and practitioners. Results from a large-scale questionnaire study (n = 1,516) showed that researchers perceive themselves to be engaged with the autism community but that community members, most notably autistic people and their families, did not share this view. Focus groups/interviews with 72 participants further identified the potential benefits and remaining challenges to involvement in research, especially regarding the distinct perspectives of different stakeholders. Researchers were skeptical about the possibilities of dramatically increasing community engagement, while community members themselves spoke about the challenges to fully understanding and influencing the research process. We suggest that the lack of a shared approach to community engagement in UK autism research represents a key roadblock to translational endeavors.
    PLoS ONE 10/2014; 9(10):e109946. DOI:10.1371/journal.pone.0109946 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Researchers have iterated that the future of synthetic biology and biotechnology lies in novel consumer applications of crossing biology with engineering. However, if the new biology’s future is to be sustainable, early and serious efforts must be made towards social sustainability. Therefore, the crux of new applications of synthetic biology and biotechnology is public understanding and acceptance. The RASVaccine is a novel recombinant design not found in nature that re-engineers a common bacteria (Salmonella) to produce a strong immune response in humans. Synthesis of the RASVaccine has the potential to improve public health as an inexpensive, noninjectable product. But how can scientists move forward to create a dialogue of creating a ‘common sense’ of this new technology in order to promote social sustainability? This paper delves into public issues raised around these novel technologies and uses the RASVaccine as an example of meeting the public with a common sense of its possibilities and limitations.
    NanoEthics 06/2014; DOI:10.1007/s11569-014-0198-6
    This article is viewable in ResearchGate's enriched format

Full-text (4 Sources)

Download
41 Downloads
Available from
May 29, 2014